BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26561785)

  • 1. Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases.
    Zhang Y; Blanden MJ; Sudheer Ch; Gangopadhyay SA; Rashidian M; Hougland JL; Distefano MD
    Bioconjug Chem; 2015 Dec; 26(12):2542-53. PubMed ID: 26561785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Selective Enzymatic Labeling of Designed Ankyrin Repeat Proteins Using Protein Farnesyltransferase.
    Zhang Y; Auger S; Schaefer JV; Plückthun A; Distefano MD
    Methods Mol Biol; 2019; 2033():207-219. PubMed ID: 31332756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoenzymatic reversible immobilization and labeling of proteins without prior purification.
    Rashidian M; Song JM; Pricer RE; Distefano MD
    J Am Chem Soc; 2012 May; 134(20):8455-67. PubMed ID: 22435540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic isoprenoid analogues for the study of prenylated proteins: Fluorescent imaging and proteomic applications.
    Wang YC; Distefano MD
    Bioorg Chem; 2016 Feb; 64():59-65. PubMed ID: 26709869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of protein prenylation in vitro and in vivo using functionalized phosphoisoprenoids.
    Nguyen UT; Wu Y; Goodall A; Alexandrov K
    Curr Protoc Protein Sci; 2010 Nov; Chapter 14():Unit14.3. PubMed ID: 21104984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
    Reid TS; Terry KL; Casey PJ; Beese LS
    J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase.
    Turek-Etienne TC; Strickland CL; Distefano MD
    Biochemistry; 2003 Apr; 42(13):3716-24. PubMed ID: 12667062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering protein farnesyltransferase for enzymatic protein labeling applications.
    Dozier JK; Khatwani SL; Wollack JW; Wang YC; Schmidt-Dannert C; Distefano MD
    Bioconjug Chem; 2014 Jul; 25(7):1203-12. PubMed ID: 24946229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted substrate specificity for the geranylgeranyltransferase-I enzyme in Cryptococcus neoformans: implications for virulence.
    Selvig K; Ballou ER; Nichols CB; Alspaugh JA
    Eukaryot Cell; 2013 Nov; 12(11):1462-71. PubMed ID: 24014765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific labeling of proteins and peptides with trans-cyclooctene containing handles capable of tetrazine ligation.
    Wollack JW; Monson BJ; Dozier JK; Dalluge JJ; Poss K; Hilderbrand SA; Distefano MD
    Chem Biol Drug Des; 2014 Aug; 84(2):140-7. PubMed ID: 24899362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Labeling of Prenylated Proteins Using Alkyne-Modified Isoprenoid Analogues.
    Suazo KF; Hurben AK; Liu K; Xu F; Thao P; Sudheer C; Li L; Distefano MD
    Curr Protoc Chem Biol; 2018 Sep; 10(3):e46. PubMed ID: 30058775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient farnesylation of an extended C-terminal C(
    Blanden MJ; Suazo KF; Hildebrandt ER; Hardgrove DS; Patel M; Saunders WP; Distefano MD; Schmidt WK; Hougland JL
    J Biol Chem; 2018 Feb; 293(8):2770-2785. PubMed ID: 29282289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein prenyltransferases.
    Maurer-Stroh S; Washietl S; Eisenhaber F
    Genome Biol; 2003; 4(4):212. PubMed ID: 12702202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid analysis of protein farnesyltransferase substrate specificity using peptide libraries and isoprenoid diphosphate analogues.
    Wang YC; Dozier JK; Beese LS; Distefano MD
    ACS Chem Biol; 2014 Aug; 9(8):1726-35. PubMed ID: 24841702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening the Utility of Farnesyltransferase-Catalyzed Protein Labeling Using Norbornene-Tetrazine Click Chemistry.
    Auger SA; Venkatachalapathy S; Suazo KFG; Wang Y; Sarkis AW; Bernhagen K; Justyna K; Schaefer JV; Wollack JW; Plückthun A; Li L; Distefano MD
    Bioconjug Chem; 2024 Apr; ():. PubMed ID: 38654427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic incorporation of orthogonally reactive prenylazide groups into peptides using geranylazide diphosphate via protein farnesyltransferase: implications for selective protein labeling.
    Rose MW; Xu J; Kale TA; O'Doherty G; Barany G; Distefano MD
    Biopolymers; 2005; 80(2-3):164-71. PubMed ID: 15810014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted reengineering of protein geranylgeranyltransferase type I selectivity functionally implicates active-site residues in protein-substrate recognition.
    Gangopadhyay SA; Losito EL; Hougland JL
    Biochemistry; 2014 Jan; 53(2):434-46. PubMed ID: 24344934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of mammalian protein geranylgeranyltransferase type-I.
    Taylor JS; Reid TS; Terry KL; Casey PJ; Beese LS
    EMBO J; 2003 Nov; 22(22):5963-74. PubMed ID: 14609943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymology and biology of CaaX protein prenylation.
    Fu HW; Casey PJ
    Recent Prog Horm Res; 1999; 54():315-42; discussion 342-3. PubMed ID: 10548882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.